IN THIS ARTICLE

From Journal of the American Board of Family Medicine

The Fish in Secondary Prevention of Heart Disease (FISH) Survey--Primary Care Physicians and 3 Fatty Acid Prescribing Behaviors

Posted 10/25/2006

Robert C. Oh, MD, MPH; Shirley A. A. Beresford, PhD; William E. Lafferty, MD
Author Information

Abstract and Introduction

Abstract

Purpose: Consumption of fish oil has been shown to reduce mortality in patients with cardiovascular disease (CVD). This study aims to determine the frequency and associations of dietary fish prescribing by family physicians.
Methods: A 22-item survey mailed to randomly selected Washington State family physicians.
Results: Nearly all agreed that nutrition is important in CVD prevention (99%) and felt that they have an essential role in giving dietary advice (92%). The majority (57%) knew of fish oil's effectiveness in secondary prevention of CVD. However, only 17% of respondents were identified as high fish prescribers. Knowledge of fish oil's benefit in sudden death reduction was associated with higher fish prescribers in bivariate (P = .005) and multivariate analysis (OR = 2.77; 95th CI: 1.32 to 5.82). High fish prescribers were more likely to report having sufficient time to discuss dietary therapies in bivariate (P = .018) and multivariate analysis (OR = 1.43; 95th CI: 1.03 to 1.98).
Conclusions: Despite knowledge of fish oil's benefit and favorable attitudes toward nutritional therapy, family physicians infrequently recommend fish oils for their CVD patients. Strategies improving awareness of fish oil's effects on sudden death and reducing time barriers associated with dietary counseling should be explored further to increase recommendation of this important advice.

Introduction

Cardiovascular disease (CVD) remains the number one killer of men and women in the United States.[1] Although the role of dietary therapy has been integral for both primary and secondary prevention of CVD, the evidence for dietary modification and its reduction of all-cause mortality is limited.[2] The National Cholesterol and Education Program's step I and step II diets (low saturated fats, whole grain, high fruits, and vegetable diet) targets cholesterol reduction to reduce CVD.[3] Similarly, high fruit and vegetable and lower sodium diets have been shown to reduce blood pressure.[4,5] Despite evidence for benefits in CVD risk reduction, these diets have not yet shown all-cause mortality benefits. Recently, adoption of a Mediterranean diet has shown to reduce CVD and all-cause mortality in both primary and secondary prevention.[6,7] The Mediterranean diet combines intake of moderate alcohol, fruits and vegetables, low to moderate amounts of fish and poultry, little red meat, and the use of olive oil as an important source of monounsaturated fats.[8]

One specific dietary recommendation in the battle against CVD may be the increased intake of ω3 fatty acids.[9] Fatty fish such as salmon, mackerel, and herring are the primary sources of dietary ω3 fatty acids. The role of ω3 fatty acids and, more specifically, fish oil through diet or supplementation, in secondary prevention of CVD seems to be supported by cohort studies,[10,11] randomized clinical trials,[12-14] meta-analysis,[15] and systematic review.[16] Despite a recent review finding inconclusive results,[17] the majority of the evidence seems to support the use of fish oils in secondary prevention of CVD.

Several theories may explain fish oil's apparent benefit in CVD. Potential mechanisms have focused on fish oil's anti-inflammatory,[18] anti-thrombotic,[19] and potent triglyceride-lowering effect.[20] Other studies have focused on antiarrhythmic[21,22] properties of ω3 fatty acids in the reduction of sudden cardiac death. A large Italian study showed that 1 g of fish oil via diet or through supplementation decreased all-cause mortality by 16%-nearly all the benefit coming from reductions in sudden death.[23] Due to the mounting evidence of the beneficial effects of ω3 fatty acids, the American Heart Association (AHA) updated its scientific statement in 2002.[24] For patients with documented coronary artery disease, the AHA recommends 1 g of fish oil for all patients via diet or supplementation. It is unclear if physicians are making these recommendations to patients who would most benefit because no studies to date have looked at the frequency of general or fish-specific nutrition counseling by physicians for patients with known CVD. This study aims to determine the practices and associations of dietary fish prescribing among family physicians and to investigate their knowledge of fish oil supplementation and attitudes toward dietary practices.

Section 1 of 5
 

References

  1. Mortality Data from the National Vital Statistics System. Accessed on May 12, 2005 at: [http://www.cdc.gov/nchs/about/major/dvs/mortdata.htm].
  2. Kromhout D, Menotti A, Kesteloot H, Sans S. Prevention of coronary heart disease by diet and lifestyle. Evidence from prospective cross-cultural, cohort and intervention studies. Circulation 2002; 105: 893-8.
  3. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
  4. Appel LJ, Moore TJ, Obarzanek E, et al, for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117-24.
  5. Sacks FM, Svetley LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 334: 3-10.
  6. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-608.
  7. de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
  8. American Heart Association. What is the "Mediterranean" diet? Accessed December 11, 2005 at: [http://www.americanheart.org/presenter.jhtml?identifier=4644].
  9. Yancy WS, Westman EC, French PA, Califf RM. Diets and clinical coronary events: the truth is out there. Circulation 2003; 107: 10-6.
  10. Kromhout D, Bosschieter EB, de Lezenne CC. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-9.
  11. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336: 1046-53.
  12. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther 1997; 11: 485-91.
  13. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2: 757-61.
  14. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
  15. Bucher HC, Hengstler P, Schindler C, et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304.
  16. Wang C, Chung M, Lichtenstein A, et al. Effects of ω3 fatty acids on cardiovascular disease. Evidence report echnology assessment no. 94 (prepared by Tufts-New England Medical Center Evidence-based Practice Center, under contract no. 290-02-0022). AHRQ Publication No. 04-E009-2. Rockville (MD): Agency for Healthcare Research and Quality. March 2004.
  17. Hooper L, Thompson RL, Harrison RA, et al. Omega-3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004; (4): CD003177.
  18. Endres S, Ghorbani R, Kelly VE, et al. The effect of dietary supplementation with n-3 fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-70.
  19. Holub BJ. Clinical nutrition: 4. omega-3 fatty acids in cardiovascular care. CMAJ 2002; 166: 608-15.
  20. Balk E, Chung M, Lichtenstein A, et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evidence report echnology assessment no. 93 (prepared by Tufts-New England Medical Center Evidence-based Practice Center under contract no. 290-02-0022). AHRQ Publication No. 04-E010-2. Rockville (MD): Agency for Healthcare Research and Quality. March 2004.
  21. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107: 2646-52.
  22. Dallongeville J, Yamell J, Ducimetiére P, et al. Fish consumption is associated with lower heart rates. Circulation 2003; 108: 820-5.
  23. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-903.
  24. Kris-Etherton PM, Harris WS, Appel LJ. AHA scientific statement: fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-57.
  25. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361: 2017-23.
  26. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. The Cochrane Database of Systematic Reviews 2004, issue 1. art. no.: CD004937. DOI: 10.1002/14651858.
  27. Kris-Etherton PM, Lichtenstien AH, Howard BV, Steinberg D, Witztum JL. Antioxidant vitamin supplementation and cardiovascular disease. Circulation 2004; 110: 637-41.
  28. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113-8.
  29. Moore H, Adamson AJ. Nutrition interventions by primary care staff: a survey of involvement, knowledge and attitude. Public Health Nutr 2002; 5: 531-6.
  30. Levine BS, Wigren MM, Chapman DS, Kerner JF, Bergman RL, Rivlin RS. A national survey of attitudes and practices of primary-care physicians relating to nutrition: strategies for enhancing the use of clinical nutrition in medical practice. Am J Clin Nutr 1993; 57: 115-9.
  31. Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004; 69: 548-56.
  32. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997; 50: 1129-36.
  33. Studer M, Brier M, Leimenstoll B, Glass TR, Bucher HC. Effect of different antilipidemic agents and diets on mortality. Arch Intern Med 2005; 165: 725-30.
  34. Naylor CD. The complex world of prescribing behavior. JAMA 2004; 291: 104-6.
  35. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
  36. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635-45.
  37. Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 2004; 180(Suppl): S57-60.
  38. Mihalynuk TV, Scott SC, Coombs JB. Self-reported nutrition proficiency is positively correlated with the perceived quality of nutrition training of family physicians in Washington State. Am J Clin Nutr 2003; 77: 1330-6.
  39. Hiddink GJ, Hautvast J, van Woerkum CV, van't Hof MA, Fieren CJ. Cross-sectional and longitudinal analyses of nutrition guidance by primary care physicians. Eur J Clin Nutr 1999; 53 Suppl: S35-43.
  40. Kushner RF. Barriers to providing nutrition counseling by physicians: a survey of primary care practitioners. Prev Med 1995; 24: 546-52.
  41. Hiddink GJ, Hautvast JG, van Woerkum CM, Fieren CJ, van't Hof MA. Nutrition guidance by primary-care physicians: perceived barriers and low involvement. Eur J Clin Nutr 1995; 49: 842-51.
  42. Beresford SA, Curry SJ, Kristal AR, Lazovich D, Feng Z, Wagner EH. A dietary intervention in primary care practice: the eating patterns study. Am J Public Health 1997; 87: 610-6.
  43. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants. JAMA 2005; 293: 1995-2002.
  44. Hollon MF. Direct-to-consumer advertising. A haphazard approach to health promotion. JAMA 2005; 293: 2030-3.
  45. Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations. Arch Pathol Lab Med 2003; 127: 1603-5.
  46. Melanson SF, Lewandrowski EL, Flood JG, Lewandrowski KB. Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature. Arch Pathol Lab Med 2005; 129: 74-7.
  47. Oh R. Practical applications of fish oil (omega-3 fatty acids) in primary care. J Am Board Fam Pract 2005; 18: 28-36.
  48. US Food and Drug Administration. Consumer drug information sheet: Omacor. Accessed November 21, 2005 at: [http://www.fda.gov/cder/consumerinfo/druginfo/omacor.htm]
  49. Seehusen DA, Baldwin LM, Runkle GP, Clark GC. Are family physicians appropriately screening for postpartum depression? J Am Board Fam Pract 2005; 18: 104-12.
  50. Weshsler H, Levine S, Idelson RK. The physician's role in health promotion revisited-a survey of primary care practitioners. N Engl J Med 1996; 334: 996-8.
  51. Greenlund KJ, Giles WH, Keenan NL, Croft JB, Mensah GA. Physician advice, patient actions, and health-related quality of life in secondary prevention of stroke through diet and exercise. Stroke 2002; 33: 565-70.
  52. Physician advice and individual behaviors about cardiovascular disease risk reduction-seven states and Puerto Rico, 1997. MMWR Morb Mortal Wkly Rep 1999; 48: 74-7.

Related Links

Author Information

Tripler Army Medical Center, Honolulu, HI (RCO); and University of Washington School of Public Health and Community Medicine, Seattle, WA (SAAB, WEL)

Dr. Robert C. Oh takes responsibility for the overall study and data integrity. Study concept and design, Dr. Robert C. Oh, Dr. Shirley A.A. Beresford, and Dr. William E. Lafferty; drafting of manuscript, Dr. Oh; critical revision of the manuscript for important intellectual content, Dr. Robert C. Oh, Dr. Shirley A.A. Beresford, and Dr. William E. Lafferty; and statistical analysis, Dr. Robert C. Oh and Dr. Shirley A.A. Beresford.

Conflict of Interests: None reported.

J Am Board Fam Med.  2006;19(5):459-467.  ©2006 American Board of Family Medicine

 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.